RATIONALE: Subcutaneous immunotherapy changes the immune response in allergic patients and results in a reduction of the specific type 1 allergic response. The basophil activation test reflects the allergic response and can be used to follow the development of the specific changes of the immune response. We hypothesized that changes in basophil sensitivity can be used to evaluate the humoral component of this reduced allergic response.